Medicare Wrongly Paid $25M For Painkiller Refills, HHS Says

Law360, New York (September 27, 2012, 4:29 PM EDT) -- Medicare Part D improperly paid $25 million for refills of Schedule II controlled substances such as oxycodone and morphine in 2009, according to a report released Thursday by the inspector general for the U.S. Department of Health and Human Services.

Under the Controlled Substances Act, prescription drugs classified as Schedule II cannot be refilled. A new, written prescription, with the prescriber's name, address and signature, must be presented each time. But in 2009, Medicare Part D, the program's prescription drug plan, paid about $25 million for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.